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The patient was seen for her routine annual gynecologic examina-
tion, in which she reported the presence of a painful abdominal mass,
which had increased in size during the previous few months. She de-
scribed the pain as cyclical, corresponding to her menstrual cycles,
and that it reminded her of the lesion for which she had previously
been operated on. Her check-ups prior to this consultation had been
normal and no abdominal nodule had been observed.
A physical examination revealed amass located in themidline of the
abdominal wall, 3 cm above the Pfannenstiel scar. The size of the lesionFothergill sign positive. The rest of the gynecological examination wasIntroduction
Endometriosis is deﬁned as the emergence and growth of endome-
trial tissue (glands and stroma) outside of the uterus. It affects 8–15%
of the population and is most frequently found in the ovary. Extrapelvic
implantationmay occur in any organ or tissue, but is rare in the abdom-
inal wall. When it does occur there, a history of surgery, whether
laparotomy or laparoscopy, is usually present.
Malignancy of this type of endometriosis in an abdominal wall scar
may occur from just a few months until up to 18 years after surgery
(Hensen et al., 2006). The case we discuss below deals with the
malignant transformation of cesarean scar endometriosis with nodal
metastasis at preperitoneal level. This is interesting because no other
known cases have ever been reported.Case presentation
We herein present the case of a 49 year-old patient with a history of
appendectomy, two births, a cesarean section, and removal of the
endometriotic mass in the cesarean scar, 15 years before.-75, 08028 Barcelona, Spain.
s).
. Open access under CC BY license. was roughly 6 cm × 6 cm, and it was painful upon movement and was
normal.
Ultrasound scan and mammography were normal. Soft tissue ultra-
sound (abdominal wall) revealed a lesion measuring 70 × 60 mm
located in the abdominal wall, conﬁned within the mesogastrium, cau-
dal to the umbilical region, compatible with ﬁbrous soft tissue tumor
(desmoid tumor). Due to the history of the patient we were not able
to rule out endometriotic implants. Fine-needle aspiration was
performed with pap smear revealing a benign process compatible
with endometriosis (Fig. 1).
Tumor marker levels were: CA-125: 243 U/mL and CEA: b0.5 ng/mL.
With a diagnosis of abdominal wall endometriosis, surgery was sched-
uled for removal of the wall tumor and exploration of the abdominal
cavity.Surgical procedure
The intraoperative pathology of the abdominal wall nodule revealed
a mass located at the preperitoneal level with histopathologic result of
serous papillary adenocarcinoma (Fig. 2). During the exploratory lapa-
rotomy two preperitoneal nodules were observed in the right iliac
fossa and another two in the left iliac fossa, which were resected and
observed to be nodal metastases of serous papillary adenocarcinoma
(two right and one left). The surgery proceeded with bilateral
adnexectomy, omentectomy, a removal of the endometriotic mass
located in the uterine fundus, endometrial biopsy, and a thorough
assessment of the abdominal cavity with intraoperative examination
of all the specimens, none revealing neoplastic inﬁltration.
The case was evaluated by the Gynecology and Oncology Commit-
tee, which decided that an extension study with a PET/CT was to be
Fig. 1. Citological study.
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of the abdominal wall mass and another one in the splenic ﬂexure. Sur-
gical laparoscopy was performed with removal of the splenic ﬂexure,
which was reported as steatonecrosis with chronic inﬂammation. The
ﬁbrotic area in the abdominal wall mass was also resected, with the
pathology providing a benign result as well.
Subsequently, adjuvant treatmentwas administeredwith 6 cycles of
carboplatin and Taxol, plus quarterly follow-ups for clinical examination
and laboratory tests (CA-125), and semi-annual follow-ups for radiolog-
ical tests. After a 48-month follow-up the patient is disease-free.Discussion
The probability of developing endometriosis in a surgical scar is
roughly 0.03–1% (Hensen et al., 2006; Blanco et al., 2003) andmalignant
transformation is likely to occur in 0.3 to 1% of the cases (Matter et al.,
2003; Leng et al., 2006), 80% of which are located in the ovary. The prin-
cipal risk factors of malignant transformation of endometriosis include:
advanced age of the patient, if they are postmenopausal, and if the
tumor diameter of an endometriotic lesion is N9 cm (Kobayashi et al.,
2007). The probability that it exclusively affects the rectus abdominis
muscles without peritoneal inﬁltration or aponeurosis is also ratherFig. 2. Pathological study of the tumor (mlow, there have only been 18 well-described cases, and there haven't
been any cases published at all documenting extraperitoneal nodal
metastases (Gianella et al., 2010).
Abdominal scar endometriosis presents as a mass in the abdominal
wall, usually adjacent to a scar from previous surgery, and is painful,
with orwithout increased size of the scar. The abdominal pain described
by the patient is usually cyclical, correlatingwith hermenstrual cycles, if
hormonal reserve is still present (Hensen et al., 2006).
Surgical history must be taken into account for the proper diagnosis.
Imaging techniques can also be useful. As a ﬁrst choice, soft tissue ultra-
sound is recommended, complementing it with ultrasound-guided
ﬁne-needle aspiration of themass.When there is a suspected diagnosis,
as in our case (due to the history of the patient), serum levels of CA-125
are requested. Non-invasive diagnostic tests have a very low sensitivity
in such cases.
In spite of all these tests, the deﬁnitive histopathological diagnosis
was serous papillary adenocarcinoma.
The differential diagnosis with palpable masses in the abdominal
wall should include: hernia, hematoma, lymphadenopathy, lymphoma,
lipoma, abscess, subcutaneous cyst, neuroma, soft tissue sarcoma,
desmoid tumor or metastasis.
The most frequent extragonadal sites of malignant endometriosis
are (N50% of the cases): the rectovaginal septum, the colon and the vag-
inal wall (Bats et al., 2008). In our case, the tumor was located in the
preperitoneal space, affecting the rectus abdominis muscles. Therefore,
the Fothergill sign was not useful in differentiating it from a rectus
sheath hematoma or any other pathology exclusively affecting the
abdominal wall muscles.
Themost interesting aspect of the case is the nodalmetastases, since
it is the ﬁrst case described in literature. Being a preperitoneal tumor,
the nodal metastases follow the pattern of tumor spread that affects
the abdominal wall muscles. When the primary lesion is located in the
infraumbilical region, these metastases drain to the superﬁcial inguinal
chains.When the lesion is in the supraumbilical region, nodalmetastatic
spread may drain to the axillary chains.
CA-125 levels in the blood might be slightly elevated however it is
a less speciﬁc biomarker. Many studies have evaluated different
biomarkers for predicting or excluding endometriosis.
Recently, one interesting study showed that CRP serum levels were
signiﬁcantly higher in patients affected by endometriosis than in
healthy patients. Similarly, other studies have shown that patients
with mild endometriosis had lower anti-Müllerian hormone levels
compared to patients without disease.acroscopic and microscopica study).
Fig. 3. Endometriosis carcinogenesis.
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in follistatin serum levels in patients with endometrioma when
compared to patients affected by other types of benign ovarian cysts.
Studies are also underway regarding other probable and more
speciﬁc biomarkers of ovarian carcinoma and endometriosis, such as
the HE4 protein (human epididymis protein 4) combined with CA-125.
Evidently, surgery is the deﬁnitive therapeutic approach. In our case,
the patient was scheduled for surgery under the assumption of a benign
diagnosis (abdominal wall endometrioma) in order to resect the mass
and thoroughly examine the abdominal cavity.
The majority of carcinomas derived from endometriosis are of
endometrioid or clear cell histologic type, in some series accounting
for 70% of the subtypes (Modesitt et al., 2002). Our case was a serous
papillary carcinoma, malignized from an endometriotic lesion in a
cesarean scar. Although intracavitary malignization is well known,
extraperitoneal malignization is not so common. In addition to the
peculiarity of this ﬁnding, the absence of a primary ovarian lesion
and the presence of extraperitoneal nodal metastasis make this a one-
of-a-kind case.
Several molecular factors have been found to be involved in the
association of endometriosis with ovarian cancer. They include: p53
alterations, PTEN silencing, K-Ras mutations and even expression of
HNF-1β (especially in clear cell tumors). It's known that the micro-
environments of endometriosis and endometriosis associated ovarian
cancer share similar cytokines and mediators. Whether this similarity
represents a link between endometriosis and endometriosis associated
ovarian cancer or simply an employment of common signaling mole-
cules to two separate lesions remains to be seen (Worley et al., 2013).
The molecular mechanisms, however, remain unclear.
One hypothetical model describing the pathogenesis of malignant
transformation of endometriosis is from the Japanese Society of Clinical
Oncology, which examines three simple and typical mechanisms of
carcinogenesis (Fig. 3).
The ﬁrst speculates that the endometriotic epithelium serves as a
precursor of cancer in the same way that the surface epithelium of
a normal ovary gives rise to ovarian tumors and contributes to the
emergence of epithelial tumors, epithelial–stromal tumors, both, or
borderline tumors.The secondmechanism refers to similarities in the carcinogenic pro-
cess of endometrial neoplasia, which, under the inﬂuence of unopposed
estrogens, basically leads to an endometrioid tumor.
The third describes the idea that this carcinogenesis is strongly inﬂu-
enced by the microenvironment within the endometriotic lesion and
that continued exposure to oxidative stress and inﬂammation promotes
a resistant and slow-growing phenotype of malignant tumors such as
clear cell carcinoma.
Although this hypothesis may be simplistic and require further
validation, it remains a useful model of preliminary carcinogenic mech-
anisms in endometriosis (Mandai et al., 2009).
These patients cannot be treated in the sameway as thosewith ovar-
ian neoplasia, since this is not the lesion to be treated, nor does it have
the same dissemination mechanism. The literature primarily describes
surgical treatment, the surgical removal of the disease, while ruling
out metastasis in possible organs or epithelia at risk. For this reason
we decided to remove all the macroscopically visible disease along
with the omentum, both ovaries and an endometrial biopsy.
As for the adjuvant therapy, the patientwas treatedwith carboplatin
and Taxol because serous papillary histologies tend to respond to this
combination of chemotherapy.Conclusions
This is a unique case since no otherwell-documented cases ofmalig-
nant transformation of endometriosis with preperitoneal lymph node
metastasis have been described in literature. Because this is such a
rare etiology, there is very little experience in the management of
these types of patients to help guide us in considering an ideal treat-
ment strategy. Further molecular studies are needed to shed light on
the mechanisms of the pathogenesis of this disease. Nevertheless, we
are certain that the proper treatment of endometriosis, or the monitor-
ing of these patients, can either prevent the very occurrence of a malig-
nant lesion or allow for diagnosis and treatment at an early stage.Conﬂict of interest statement
The authors declare that there is no conﬂict of interest.
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